Health • April 3, 2026
Breakthrough ALS study launches as drug aims to slow disease progression
Originally published on Fox News Health
The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve function in early-stage patients.
The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve function in early-stage patients.
Originally published on Fox News Health.